Sign Out
VECTIBIX is contraindicated in patients with a history of life-threatening hypersensitivity reactions to panitumumab or any of the excipients.
For patients with mutant RAS mCRC or for whom RAS status is unknown, the combination of VECTIBIX with oxaliplatin-based chemotherapy is contraindicated (see Precautions).
